The association between multiple sclerosis (MS) pathogenesis and Hsp90β has been suggested by the presence of anti‐Hsp90β antibodies in the cerebrospinal fluid (CSF) of MS patients [130]. This evidence concerns the gene HSP90AB1 and myeloid sarcoma.